Teladoc CEO Jason Gorevic is out at the telehealth giant amid increasing scrutiny of generalist telehealth players.
Why it matters: The change comes as eyes turn to the poor performance of generalist telehealth businesses, including Amwell, whose stock reached a historic low this week following an Axios investigation.
